Evotec Launches the First Translational BRIDGE in Germany in Collaboration with Bristol-Myers
Evotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreThe unique 3DProSeed® ready-to-use 96-well microtiter plate developed by Ectica Technologies contains pre-assembled synthetic hydrogels, ready for screening 3D cell
Read moreThe cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read moreTissueGnostics has launched a new cutting-edge compact digital brightfield slide scanner with remote real-time viewing and live stitching modes combined
Read moreThe NYONE® is a new-gen compact medium-throughput cell imager, designed as an ideal solution to save on costs and laboratory
Read moreThe CELLAVISTA® 4 is a cutting-edge automated ultrahigh-throughput imaging system able to scan a 96 well microplate at 10X magnification
Read moreUtilising Surface Plasmon Resonance (SPR) analysis for drug development or drug discovery can make a big impact. SPR analysis can
Read moreBioNTech and InstaDeep have entered into an agreement to establish a joint AI Innovation Lab in London, United Kingdom and
Read more